Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tES Modalities for the Treatment of ADHD

NCT: NCT06974136 · COMPLETED

NCT IDNCT06974136
StatusCOMPLETED
Start Date2025-03-30
Completion2026-05-01
SponsorThe National Brain Mapping Laboratory (NBML) (OTHER)
First posted
Last updated

Brief Summary

This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.

Frequently Asked Questions

What is tES Modalities for the Treatment of ADHD?

tES Modalities for the Treatment of ADHD is a clinical trial registered under NCT06974136. Current status: COMPLETED.

What is the status of NCT06974136?

The current status of NCT06974136 (tES Modalities for the Treatment of ADHD) is: COMPLETED.

When did tES Modalities for the Treatment of ADHD start?

tES Modalities for the Treatment of ADHD started on 2025-03-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑